{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:16:02Z","timestamp":1767888962704,"version":"3.49.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4052,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1538-7836.2011.04481.x","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T05:38:22Z","timestamp":1320125902000},"page":"2143-2152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["RNA\u2010based therapeutic approaches for coagulation factor deficiencies"],"prefix":"10.1016","volume":"9","author":[{"given":"M.","family":"PINOTTI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"BERNARDI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"DAL MAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"PAGANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0010","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(03)13405-8","article-title":"Haemophilias A and B","volume":"361","author":"Bolton\u2010Maggs","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0015","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2004-02-0595","article-title":"Recessively inherited coagulation disorders","volume":"104","author":"Mannucci","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2516.2008.01718.x","article-title":"Progress in the molecular biology of inherited bleeding disorders","volume":"14","author":"Pipe","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0268-960X(03)00038-9","article-title":"Prophylactic factor replacement in hemophilia","volume":"18","author":"Carcao","year":"2004","journal-title":"Blood Rev"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2141.2007.06942.x","article-title":"Gene therapy for haemophilia","volume":"140","author":"Murphy","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jgm.1500","article-title":"Gene therapy strategies for hemophilia: benefits versus risks","volume":"12","author":"Petrus","year":"2010","journal-title":"J Gene Med"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0040","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2174\/156652305774329249","article-title":"RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes","volume":"5","author":"Wilton","year":"2005","journal-title":"Curr Gene Ther"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0045","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1371\/journal.pgen.0030109","article-title":"Modulating the expression of disease genes with RNA\u2010based therapy","volume":"3","author":"Wood","year":"2007","journal-title":"PLoS Genet"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0050","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cell.2009.02.010","article-title":"RNA\u2010based therapeutics: ready for delivery?","volume":"136","author":"Bonetta","year":"2009","journal-title":"Cell"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0055","first-page":"116","article-title":"Progress toward therapy with antisense\u2010mediated splicing modulation","volume":"11","author":"Du","year":"2009","journal-title":"Curr Opin Mol Ther"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4161\/rna.7.4.12206","article-title":"Repair of pre\u2010mRNA splicing: prospects for a therapy for spinal muscular atrophy","volume":"7","author":"Nlend Nlend","year":"2010","journal-title":"RNA Biol"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.2649","article-title":"The pathobiology of splicing","volume":"220","author":"Ward","year":"2010","journal-title":"J Pathol"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0070","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.tig.2011.02.004","article-title":"Genetic therapies for RNA mis\u2010splicing diseases","volume":"27","author":"Hammond","year":"2011","journal-title":"Trends Genet"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0075","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1182\/blood-2007-10-117440","article-title":"U1\u2010snRNA\u2010mediated rescue of mRNA processing in severe factor VII deficiency","volume":"111","author":"Pinotti","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0080","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1182\/blood-2009-03-207613","article-title":"Rescue of coagulation factor VII function by the U1 +5A snRNA","volume":"113","author":"Pinotti","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/jmg.40.3.220","article-title":"Identification of a mutation that perturbs NF1 agene splicing using genomic DNA samples and a minigene assay","volume":"40","author":"Baralle","year":"2003","journal-title":"J Med Genet"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/humu.20076","article-title":"TCIRG1\u2010dependent recessive osteopetrosis: mutation analysis, functional identification of the splicing defects, and in vitro rescue by U1 snRNA","volume":"24","author":"Susani","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/humu.20861","article-title":"Therapeutic strategy to rescue mutation\u2010induced exon skipping in rhodopsin by adaptation of U1 snRNA","volume":"30","author":"Tanner","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0100","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ajhg.2010.08.016","article-title":"Correct mRNA processing at a mutant TT splice donor in FANCC ameliorates the clinical phenotype in patients and is enhanced by delivery of suppressor U1 snRNAs","volume":"87","author":"Hartmann","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0105","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/humu.21509","article-title":"U1 snRNA\u2010mediated gene therapeutic correction of splice defects caused by an exceptionally mild BBS mutation","volume":"32","author":"Schmid","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0110","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/mt.2011.7","article-title":"Gene therapeutic approach using mutation\u2010adapted U1 snRNA to correct a RPGR splice defect in patient\u2010derived cells","volume":"19","author":"Glaus","year":"2011","journal-title":"Mol Ther"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrg775","article-title":"Listening to silence and understanding nonsense: exonic mutations that affect splicing","volume":"3","author":"Cartegni","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/gad.1048803","article-title":"Pre\u2010mRNA splicing and human disease","volume":"17","author":"Faustino","year":"2003","journal-title":"Genes Dev"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrg1327","article-title":"Genomic variants in exons and introns: identifying the splicing spoilers","volume":"5","author":"Pagani","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0130","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2777","article-title":"Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches","volume":"10","author":"Chen","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature08909","article-title":"Expansion of the eukaryotic proteome by alternative splicing","volume":"463","author":"Nilsen","year":"2010","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0140","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nn.2565","article-title":"Therapy development in spinal muscular atrophy","volume":"13","author":"Sendtner","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0145","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy","volume":"3","author":"Passini","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0168-9525(94)90233-X","article-title":"Mechanisms for selecting 5\u2032 splice sites in mammalian pre\u2010mRNA splicing","volume":"10","author":"Horowitz","year":"1994","journal-title":"Trends Genet"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0155","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1261\/rna.5196404","article-title":"Comparative analysis detects dependencies among the 5\u2032 splice\u2010site positions","volume":"10","author":"Carmel","year":"2004","journal-title":"RNA"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00210743","article-title":"The mutational spectrum of single base\u2013pair substitutions in mRNA splice junctions of human genes: causes and consequences","volume":"90","author":"Krawczak","year":"1992","journal-title":"Hum Genet"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/humu.20400","article-title":"Single base\u2010pair substitutions in exon\u2010intron junctions of human genes: nature, distribution, and consequences for mRNA splicing","volume":"28","author":"Krawczak","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0170","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1093\/nar\/gkm402","article-title":"Aberrant 5\u2032 splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization","volume":"35","author":"Buratti","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0175","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood.V92.5.1646.417k16_1646_1651","article-title":"Molecular mechanisms of FVII deficiency: expression of mutations clustered in the IVS7 donor splice site of factor VII gene","volume":"92","author":"Pinotti","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0185","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1073\/pnas.91.22.10470","article-title":"Suppression of mammalian 5\u2032 splice\u2010site defects by U1 small nuclear RNAs from a distance","volume":"91","author":"Cohen","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0190","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/mt.2010.123","article-title":"Exon skipping and duchenne muscular dystrophy therapy: selection of the most active U1 snRNA antisense able to induce dystrophin exon 51 skipping","volume":"18","author":"Incitti","year":"2010","journal-title":"Mol Ther"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0195","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1128\/MCB.21.8.2815-2825.2001","article-title":"Reduction of target gene expression by a modified U1 snRNA","volume":"21","author":"Beckley","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(85)80111-2","article-title":"Trans\u2010splicing of mRNA precursors","volume":"42","author":"Solnick","year":"1985","journal-title":"Cell"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molmed.2004.04.007","article-title":"RNA repair using spliceosome\u2010mediated RNA trans\u2010splicing","volume":"10","author":"Yang","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0210","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nm900","article-title":"Phenotype correction of hemophilia A mice by spliceosome\u2010mediated RNA trans\u2010splicing","volume":"9","author":"Chao","year":"2003","journal-title":"Nat Med"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1523\/JNEUROSCI.4489-09.2010","article-title":"Trans\u2010splicing\u2010mediated improvement in a severe mouse model of spinal muscular atrophy","volume":"30","author":"Coady","year":"2010","journal-title":"J Neurosci"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406010337","article-title":"RNA repair for haemophilia A","volume":"8","author":"Chao","year":"2006","journal-title":"Expert Rev Mol Med"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/nar\/26.1.265","article-title":"Haemophilia B: database of point mutations and short additions and deletions \u2013 eighth edition","volume":"26","author":"Giannelli","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0230","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/nar\/26.1.216","article-title":"The factor VIII structure and mutation resource site: HAMSTeRS version 4","volume":"26","author":"Kemball\u2010Cook","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0235","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/sj.ejhg.5201649","article-title":"Nonsense\u2010mediated mRNA decay modulates clinical outcome of genetic disease","volume":"14","author":"Khajavi","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0240","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0968-0004(00)01669-8","article-title":"Translational termination comes of age","volume":"25","author":"Kisselev","year":"2000","journal-title":"Trends Biochem Sci"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/3-540-28217-3_1","article-title":"Polypeptide chain termination and stop codon readthrough on eukaryotic ribosomes","volume":"155","author":"Rospert","year":"2005","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0250","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1101\/sqb.2001.66.459","article-title":"Modulation of translation termination mechanisms by cis\u2010 and trans\u2010acting factors","volume":"66","author":"Janzen","year":"2001","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0255","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/jmbi.1996.0526","article-title":"RNA sequence determinants for aminoglycoside binding to an A\u2010site rRNA model oligonucleotide","volume":"262","author":"Recht","year":"1996","journal-title":"J Mol Biol"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0260","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/embo-reports\/kve062","article-title":"Structural basis for selectivity and toxicity of ribosomal antibiotics","volume":"2","author":"B\u00f6ttger","year":"2001","journal-title":"EMBO Rep"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0265","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1093\/nar\/13.17.6265","article-title":"Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G\u2010418 and paromomycin","volume":"13","author":"Burke","year":"1985","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0270","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.clpt.6100012","article-title":"Aminoglycoside\u2010induced translational read\u2010through in disease: overcoming nonsense mutations by pharmacogenetic therapy","volume":"81","author":"Zingman","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0275","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1182\/blood-2005-03-1307","article-title":"Aminoglycoside suppression of nonsense mutations in severe hemophilia","volume":"106","author":"James","year":"2005","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2011.04481.x_bb0280","first-page":"CD043","article-title":"Administration of gentamicin does not increase factor levels in severe hemophilia\u2010B due to premature termination codons","volume":"1","author":"Srivastava","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0285","doi-asserted-by":"crossref","first-page":"15394","DOI":"10.1073\/pnas.0610878104","article-title":"A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin","volume":"104","author":"Yang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0290","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1538-7836.2006.01915.x","article-title":"Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII","volume":"4","author":"Pinotti","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0295","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1538-7836.2006.02057.x","article-title":"Gentamicin induces sub\u2010therapeutic levels of coagulation factor VII in patients with nonsense mutations","volume":"4","author":"Pinotti","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0300","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0022-2836(92)90920-F","article-title":"Influence of codon context on UGA suppression and readthrough","volume":"225","author":"Kopelowitz","year":"1992","journal-title":"J Mol Biol"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0305","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/j.1460-2075.1995.tb06985.x","article-title":"The identity of the base following the stop codon determines the efficiency of in vivo translational termination in Escherichia coli","volume":"14","author":"Poole","year":"1995","journal-title":"EMBO J"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0310","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/jmbi.1995.0438","article-title":"The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae","volume":"251","author":"Bonetti","year":"1995","journal-title":"J Mol Biol"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0315","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S1355838200000716","article-title":"Aminoglycoside antibiotics mediate context\u2010dependent suppression of termination codons in a mammalian translation system","volume":"6","author":"Manuvakhova","year":"2000","journal-title":"RNA"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0320","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","article-title":"Aminoglycosides: nephrotoxicity","volume":"43","author":"Mingeot\u2010Leclercq","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0325","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0330","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0091270006297140","article-title":"Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single\u2010 and multiple\u2010dose administration to healthy male and female adult volunteers","volume":"47","author":"Hirawat","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0335","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00063030-200923030-00003","article-title":"Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development","volume":"23","author":"Rowe","year":"2009","journal-title":"BioDrugs"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0340","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(08)61168-X","article-title":"Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial","volume":"372","author":"Kerem","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0345","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.201001-0137OC","article-title":"Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis","volume":"182","author":"Sermet\u2010Gaudelus","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1538-7836.2011.04481.x_bb0350","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.coph.2010.03.005","article-title":"Molecular treatments in Duchenne muscular dystrophy","volume":"10","author":"Guglieri","year":"2010","journal-title":"Curr Opin Pharmacol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2011.04481.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622074347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622074347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2011.04481.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:54:14Z","timestamp":1761533654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622074347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1538783622074347"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04481.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA\u2010based therapeutic approaches for coagulation factor deficiencies","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04481.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}